GSK recalls 600,000 Ventolin Inhalers from US
Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.
The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.
The inhalers, according to reports, have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.
“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”
The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.
About author
You might also like
NARD pushes for better services in public hospitals
Says strike never the best option to get demands ABUJA – Newly-elected president, National Association of Resident Doctors of Nigeria (NARD), Dr Chinaka Ugochukwu, has said the priority of the group
Measles cases up 300 percent in 2019, WHO says
UNICEF expresses concern More than 112,000 cases of measles already reporter this year ‘Many countries are in the midst of sizeable measles outbreaks,’ WHO says Measles cases have continued to
Merck empowers African women cancer survivors
… Launches Merck-More-than-a-Patient Initiative NAIROBI, Kenya, November 2, 2016: Merck, a leading science and technology company, today announced the kick off of “Merck More than a Patient,” a new initiative
0 Comments
No Comments Yet!
You can be first to comment this post!